^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BinD19

    i
    Other names: BinD19, autologous T cells transduced with CD19 TCR-ζ/4-1BB vector, BinD-19, BinD 19
    Associations

    News

    Trials
    Company:
    Shenzhen BinDeBio
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over3years
    A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects (clinicaltrials.gov)
    P1/2, N=20, Active, not recruiting, Shenzhen BinDeBio Ltd. | Recruiting --> Active, not recruiting | Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Jun 2020 --> May 2021
    Clinical • Enrollment closed • Trial completion date • Trial primary completion date
    |
    CD19 (CD19 Molecule)
    |
    BinD19
    over3years
    A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects (clinicaltrials.gov)
    P1/2, N=24, Active, not recruiting, Shenzhen BinDeBio Ltd. | Trial completion date: Dec 2020 --> Dec 2021 | Trial primary completion date: Jun 2020 --> May 2021
    Clinical • Trial completion date • Trial primary completion date
    |
    CD19 (CD19 Molecule)
    |
    BinD19